Page last updated: 2024-11-01

niclosamide and Congenital Zika Syndrome

niclosamide has been researched along with Congenital Zika Syndrome in 5 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Research Excerpts

ExcerptRelevanceReference
" Here, we screened a small library of niclosamide derivatives and identified a new analogue with improved pharmacokinetic properties."5.56JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both ( Butler, D; Chen, H; D'Brant, L; Fan, X; Hu, S; Koetzner, CA; Kramer, LD; Kuo, L; Lang, Y; Li, H; Li, Z; Rugenstein, N; Samrat, SK; Tharappel, AM; Trudeau, N; Xu, J; Zhang, J; Zhang, QY; Zhou, J, 2020)
" Here, we screened a small library of niclosamide derivatives and identified a new analogue with improved pharmacokinetic properties."1.56JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both ( Butler, D; Chen, H; D'Brant, L; Fan, X; Hu, S; Koetzner, CA; Kramer, LD; Kuo, L; Lang, Y; Li, H; Li, Z; Rugenstein, N; Samrat, SK; Tharappel, AM; Trudeau, N; Xu, J; Zhang, J; Zhang, QY; Zhou, J, 2020)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W1
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A2
Nath, A1
Yang, W1
Liu, LB1
Liu, FL1
Wu, YH1
Zhen, ZD1
Fan, DY1
Sheng, ZY1
Song, ZR1
Chang, JT1
Zheng, YT1
An, J1
Wang, PG1
Huang, Y1
Li, Q1
Kang, L1
Li, B1
Ye, H1
Duan, X1
Xie, H1
Jiang, M1
Li, S1
Zhu, Y1
Tan, Q1
Chen, L1
Li, Z1
Xu, J1
Lang, Y1
Fan, X1
Kuo, L1
D'Brant, L1
Hu, S1
Samrat, SK1
Trudeau, N1
Tharappel, AM1
Rugenstein, N1
Koetzner, CA1
Zhang, J1
Chen, H1
Kramer, LD1
Butler, D1
Zhang, QY1
Zhou, J1
Li, H1
Xu, M1
Lee, EM1
Wen, Z1
Cheng, Y1
Huang, WK1
Qian, X1
Tcw, J1
Kouznetsova, J1
Ogden, SC1
Hammack, C1
Jacob, F1
Nguyen, HN1
Itkin, M1
Hanna, C1
Shinn, P1
Allen, C1
Michael, SG1
Huang, W1
Christian, KM1
Goate, A1
Brennand, KJ1
Huang, R1
Xia, M1
Ming, GL1
Zheng, W1
Song, H1
Tang, H1

Other Studies

5 other studies available for niclosamide and Congenital Zika Syndrome

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
Single-cell RNA sequencing reveals the fragility of male spermatogenic cells to Zika virus-induced complement activation.
    Nature communications, 2023, 04-29, Volume: 14, Issue:1

    Topics: Animals; Complement Activation; Male; Mice; Niclosamide; Sequence Analysis, RNA; Zika Virus; Zika Vi

2023
Mitophagy Activation Targeting PINK1 Is an Effective Treatment to Inhibit Zika Virus Replication.
    ACS infectious diseases, 2023, 07-14, Volume: 9, Issue:7

    Topics: Animals; Mice; Mitophagy; Niclosamide; Protein Kinases; Ubiquitin; Zika Virus; Zika Virus Infection

2023
JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both
    ACS infectious diseases, 2020, 10-09, Volume: 6, Issue:10

    Topics: Animals; Flavivirus; Humans; Niclosamide; Viral Nonstructural Proteins; Zika Virus; Zika Virus Infec

2020
Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen.
    Nature medicine, 2016, Volume: 22, Issue:10

    Topics: Astrocytes; Brain; Caspase 3; Caspase Inhibitors; Cell Death; Cell Line; Drug Repositioning; Humans;

2016